Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Accenture
Johnson and Johnson
Baxter
Deloitte
Cipla
US Department of Justice
UBS
Queensland Health

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074523

« Back to Dashboard

NDA 074523 describes METROMIDOL, which is a drug marketed by Labs Af and is included in one NDA. Additional details are available on the METROMIDOL profile page.

The generic ingredient in METROMIDOL is metronidazole. There are eighteen drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 074523
Tradename:METROMIDOL
Applicant:Labs Af
Ingredient:metronidazole
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 074523

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Oct 24, 1996TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Oct 24, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Colorcon
Citi
Deloitte
Chinese Patent Office
Moodys
McKesson
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.